EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:37941 - clopidogrel
| Formula | C16H16ClNO2S |
| Net Charge | 0 |
| Average Mass | 321.829 |
| Monoisotopic Mass | 321.05903 |
| SMILES | COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 |
| InChI | InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1 |
| InChIKey | GKTWGGQPFAXNFI-HNNXBMFYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | antiviral agent A substance that destroys or inhibits replication of viruses. anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. P2Y12 receptor antagonist An antagonist at the P2Y12 receptor antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. |
| Applications: | renoprotective agent Any compound that is able to prevent damage to the kidneys. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. platelet aggregation inhibitor A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. hypoglycemic agent A drug which lowers the blood glucose level. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. anticoagulant An agent that prevents blood clotting. anti-asthmatic agent Any compound that has anti-asthmatic effects. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| clopidogrel (CHEBI:37941) has functional parent ticlopidine (CHEBI:9588) |
| clopidogrel (CHEBI:37941) has role anti-arrhythmia drug (CHEBI:38070) |
| clopidogrel (CHEBI:37941) has role anti-asthmatic agent (CHEBI:65023) |
| clopidogrel (CHEBI:37941) has role anti-HIV agent (CHEBI:64946) |
| clopidogrel (CHEBI:37941) has role antiatherosclerotic agent (CHEBI:145947) |
| clopidogrel (CHEBI:37941) has role anticoagulant (CHEBI:50249) |
| clopidogrel (CHEBI:37941) has role antidepressant (CHEBI:35469) |
| clopidogrel (CHEBI:37941) has role antihypertensive agent (CHEBI:35674) |
| clopidogrel (CHEBI:37941) has role antimicrobial agent (CHEBI:33281) |
| clopidogrel (CHEBI:37941) has role antineoplastic agent (CHEBI:35610) |
| clopidogrel (CHEBI:37941) has role antiviral agent (CHEBI:22587) |
| clopidogrel (CHEBI:37941) has role cardiovascular drug (CHEBI:35554) |
| clopidogrel (CHEBI:37941) has role hypoglycemic agent (CHEBI:35526) |
| clopidogrel (CHEBI:37941) has role ophthalmology drug (CHEBI:66981) |
| clopidogrel (CHEBI:37941) has role P2Y12 receptor antagonist (CHEBI:68563) |
| clopidogrel (CHEBI:37941) has role platelet aggregation inhibitor (CHEBI:50427) |
| clopidogrel (CHEBI:37941) has role renoprotective agent (CHEBI:231911) |
| clopidogrel (CHEBI:37941) is a methyl ester (CHEBI:25248) |
| clopidogrel (CHEBI:37941) is a monochlorobenzenes (CHEBI:83403) |
| clopidogrel (CHEBI:37941) is a thienopyridine (CHEBI:37942) |
| Incoming Relation(s) |
| clopidogrel sulfate (CHEBI:3759) has part clopidogrel (CHEBI:37941) |
| IUPAC Name |
|---|
| methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate |
| INNs | Source |
|---|---|
| clopidogrel | WHO MedNet |
| clopidogrel | WHO MedNet |
| clopidogrel | WHO MedNet |
| clopidogrelum | ChemIDplus |
| Synonyms | Source |
|---|---|
| (+)-Clopidogrel | ChEBI |
| NSC-758613 | ChEMBL |
| R 130964 | ChEMBL |
| R-130964 | ChEMBL |
| SR 25990 | ChEMBL |
| SR-25990 | ChEMBL |
| Registry Numbers | Sources |
|---|---|
| Beilstein:8151914 | Beilstein |
| CAS:113665-84-2 | ChemIDplus |
| Citations |
|---|